As per corporate shareholdings filed for Apr-2025, people matching BML Capital Management LLC publicly holds 36 stocks with a net worth of over US$ 249.4 M.
These are shares held by BML Capital Management LLC as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
---|---|---|---|---|---|---|---|---|
Neoleukin Therapeutics Inc | Bml Capital Management Llc | 17.76 | 98,664 | 1.05% | 0.00 | 1.8 M | ||
Rain Oncology Inc | Bml Capital Management Llc | 2.88 | 72,926 | 0.20% | 0.00 | 210.0 K | ||
Talaris Therapeutics Inc | Bml Capital Management Llc | 16.64 | 2,000,000 | 4.68% | 0.00 | 33.3 M | ||
Graphite Bio Inc | Bml Capital Management Llc | 29.94 | 447,416 | 0.77% | 0.00 | 13.4 M | ||
Kinnate Biopharma Inc | Bml Capital Management Llc | 0.00 | 468,210 | 0.99% | 0.00 | - | ||
Cyteir Therapeutics Inc | Bml Capital Management Llc | 3.01 | 3,654,053 | 10.15% | 0.00 | 11.0 M | ||
Reneo Pharmaceuticals Inc | Bml Capital Management Llc | 18.20 | 2,672,194 | 7.99% | 0.00 | 48.6 M | ||
Kalaris Therapeutics Inc. | Bml Capital Management Llc | 2.40 | 603,086 | 0.52% | 0.00 | 1.4 M | ||
Pieris Pharmaceuticals Inc | Bml Capital Management Llc | 13.60 | 42,130 | 3.19% | 0.00 | 573.0 K | ||
Achilles Therapeutics Plc - ADR | Bml Capital Management Llc | 1.48 | 4,100,002 | 9.98% | 0.00 | 6.1 M | ||
Aclaris Therapeutics Inc | Bml Capital Management Llc | 1.45 | 14,250,000 | 13.16% | 0.00 | 20.7 M | ||
Adverum Biotechnologies Inc | Bml Capital Management Llc | 2.25 | 2,742,317 | 13.13% | 2.27 | 6.2 M | ||
Alumis Inc. | Bml Capital Management Llc | 2.86 | 49,627 | 0.05% | NEW | 141.9 K | ||
AN2 Therapeutics Inc | Bml Capital Management Llc | 1.10 | 5,749,432 | 19.10% | 0.00 | 6.3 M | ||
Astrotech Corp | Bml Capital Management Llc | 5.85 | 220,410 | 13.01% | 0.06 | 1.3 M | ||
Athira Pharma Inc | Bml Capital Management Llc | 0.30 | 3,200,667 | 8.20% | 1.09 | 960.2 K | ||
Atea Pharmaceuticals Inc | Bml Capital Management Llc | 3.25 | 7,609,812 | 8.89% | 0.00 | 24.7 M | ||
Connect Biopharma Holdings Ltd - ADR | Bml Capital Management Llc | 1.03 | 2,093,232 | 3.77% | -0.01 | 2.2 M | ||
Elevation Oncology Inc | Bml Capital Management Llc | 0.38 | 5,890,934 | 9.95% | NEW | 2.2 M | ||
Essa Pharma Inc | Bml Capital Management Llc | 1.73 | 4,221,546 | 9.51% | 0.00 | 7.3 M | ||
HilleVax Inc | Bml Capital Management Llc | 1.86 | 20,760 | 0.04% | 0.00 | 38.6 K | ||
Ikena Oncology Inc | Bml Capital Management Llc | 1.36 | 3,710,803 | 7.69% | 0.26 | 5.0 M | ||
Kezar Life Sciences Inc | Bml Capital Management Llc | 4.52 | 408,138 | 5.59% | 4.92 | 1.8 M | ||
Lisata Therapeutics Inc | Bml Capital Management Llc | 2.48 | 216,853 | 2.52% | -0.78 | 537.8 K | ||
LAVA Therapeutics NV | Bml Capital Management Llc | 1.31 | 1,960,610 | 7.45% | NEW | 2.6 M | ||
Milestone Pharmaceuticals Inc | Bml Capital Management Llc | 1.69 | 1,136,091 | 2.12% | 0.00 | 1.9 M | ||
Nextcure Inc | Bml Capital Management Llc | 0.47 | 273,536 | 0.98% | 0.00 | 128.6 K | ||
Oramed Pharmaceuticals, Inc | Bml Capital Management Llc | 2.13 | 3,020,748 | 7.39% | 0.92 | 6.4 M | ||
PMV Pharmaceuticals Inc | Bml Capital Management Llc | 1.09 | 3,747,612 | 7.21% | 0.54 | 4.1 M | ||
Sage Therapeutics Inc | Bml Capital Management Llc | 9.30 | 135,095 | 0.22% | NEW | 1.3 M | ||
Third Harmonic Bio Inc | Bml Capital Management Llc | 5.46 | 3,824,417 | 8.47% | NEW | 20.9 M | ||
Instil Bio Inc | Bml Capital Management Llc | 27.70 | 416,720 | 6.35% | 0.25 | 11.5 M | ||
Turnstone Biologics Corp | Bml Capital Management Llc | 0.37 | 1,103,386 | 4.77% | NEW | 408.3 K | ||
Verrica Pharmaceuticals Inc | Bml Capital Management Llc | 0.58 | 174,651 | 0.19% | 0.00 | 101.3 K | ||
VistaGen Therapeutics Inc | Bml Capital Management Llc | 2.00 | 150,000 | 0.52% | 0.00 | 300 K | ||
Whitehawk Therapeutics Inc. | Bml Capital Management Llc | 2.09 | 1,890,245 | 4.01% | -0.48 | 4.0 M | ||
LENZ Therapeutics Inc. | 29.94 | - | Investor holds below 1% | |||||
Palvella Therapeutics Inc. | 22.05 | - | Investor holds below 1% |